Search in:

Diabetes, Metabolic Syndrome and Obesity Volume 12, 2019 - Issue

Submit an article Journal homepage

Open access

136

Views

CrossRef citations to date

Altmetric

Original Research

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Na Wang1 Department of Endocrinology, The Affiliated Hospital of Jining Medical University, Jining272000, People’s Republic of ChinaCorrespondence[email protected]

Tao Yang2 The 4th Department of Psychiatry, Jining Psychiatric Hospital, Jining272000, People’s Republic of China

Jie Li2 The 4th Department of Psychiatry, Jining Psychiatric Hospital, Jining272000, People’s Republic of China

Xianfeng Zhang2 The 4th Department of Psychiatry, Jining Psychiatric Hospital, Jining272000, People’s Republic of China

Pages 1513-1526 | Published online: 22 Aug 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (8)

Siva Prasad Panda. (2023) Role of DPP4 and DPP4i in Glucose Homeostasis and Cardiorenal Syndrome. Endocrine, Metabolic & Immune Disorders - Drug Targets 23:2, pages 179-187.
Crossref

Daniela Istrate & Luminita Crisan. (2022) Natural Compounds as DPP-4 Inhibitors: 3D-Similarity Search, ADME Toxicity, and Molecular Docking Approaches. Symmetry 14:9, pages 1842.
Crossref

Wenli Zhao, Le Zhou, Petr Novák, Xian Shi, Chuang Biao Lin, Xiao Zhu & Kai Yin. (2022) Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy. Journal of Diabetes Research 2022, pages 1-14.
Crossref

Bo Kyung Koo, Seoil Moon & Min Kyong Moon. (2021) Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study. BMC Geriatrics 21:1.
Crossref

Wenying Yang, Xiangjin Xu, Tao Lei, Jianhua Ma, Ling Li, Jie Shen, Binqi Ye, Sandy Zhu & Thomas Meinicke. (2020) Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial. Diabetes, Obesity and Metabolism 23:2, pages 642-647.
Crossref

Katsuya Shibuki, Shuji Shimada & Takao Aoyama. (2020) Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin. Journal of Diabetes Research 2020, pages 1-12.
Crossref

Anca Pantea Stoian, Alexandros Sachinidis, Roxana Adriana Stoica, Dragana Nikolic, Angelo Maria Patti & Ali A. Rizvi. (2020) The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes. Metabolism 109, pages 154295.
Crossref

Ibrahim El Ebrashy, Nabil El Kafrawy, Rana Raouf & Diana Yousry. (2020) Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study. Diabetes Research and Clinical Practice 162, pages 108042.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Citations (8)

Articles from other publishers (8)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date